Arabic Arabic English English French French German German
dark

Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development

Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary diseases and conditions, announced the appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Brooklyn ImmunoTherapeutics Welcomes Jay Sial as Chief Administrative Officer

Next Post

MOH: Precautionary Measures to Be Followed by Pilgrims

Related Posts
Total
0
Share